ContextVision

Mindre end 1K følgere

CONTX

Oslo Børs

Medical Equipment & Services

Health Care

Oversigt

Investorkonsensus

ContextVision is a medical technology company. The company specializes in image analysis and artificial intelligence. The company's products include advanced image enhancement software for ultrasound, MRI, X-ray and mammography. The software is used by hospitals and research institutes worldwide. The company was founded in 1983 and is headquartered in Stockholm.

Markedsværdi

-

Aktieomsætning

-

Omsætning

134,35 mio.

EBIT %

22,81 %

P/E

-

Udbytteafkast, %

-

Finanskalender

19.2

2026

Årsrapport '25

8.5

2026

Delårsrapport Q1'26

12.5

2026

Generalforsamling '26

Alle

Selskabsmeddelelser

ViserAlle indholdstyper

Selskabsmeddelelse2.12.2025, 17.45

ContextVision AB: Transactions made under the buy-back programme

Selskabsmeddelelse1.12.2025, 10.25

CONTX: Financial calendar

Selskabsmeddelelse21.11.2025, 16.10

ContextVision AB: Transactions made under the buy-back programme

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto

Følgere og notifikationer om fulgte virksomheder

Analytikerkommentarer og anbefalinger

Værktøj til at sammenligne aktier og andre populære værktøjer

Selskabsmeddelelse12.11.2025, 16.11

ContextVision AB: Transactions made under the buy-back programme

Selskabsmeddelelse6.11.2025, 07.00

ContextVision AB: Q3 interim report 2025 – Navigating market uncertainty while making solid progress with our Data Quality initiative

Selskabsmeddelelse3.11.2025, 15.50

ContextVision AB: Transactions made under the buy-back programme

Selskabsmeddelelse23.10.2025, 15.08

ContextVision AB: Transactions made under the buy-back programme

Selskabsmeddelelse14.10.2025, 15.50

ContextVision AB: Transactions made under the buy-back programme

Selskabsmeddelelse3.10.2025, 17.45

ContextVision AB: Transactions made under the buy-back programme

Selskabsmeddelelse24.9.2025, 16.00

ContextVision AB: Transactions made under the buy-back programme

Selskabsmeddelelse15.9.2025, 16.00

ContextVision AB: Transactions made under the buy-back programme

Selskabsmeddelelse3.9.2025, 07.00

ContextVision - Initiation of share buyback program

Selskabsmeddelelse26.8.2025, 06.00

CONTX: ContextVision publishes Webcast for the Q2 report 2025

Selskabsmeddelelse26.8.2025, 06.00

ContextVision AB: Q2 interim report 2025 - Customers pressured by trade uncertainty - We continue to invest to build tomorrow's solutions

Pressemeddelelse26.8.2025, 06.00

ContextVision AB: ContextVision publishes Webcast for the Q2 report 2025

Selskabsmeddelelse30.5.2025, 06.00

CONTX: ContextVision and AMRA Medical join forces to advance multimodal imaging in liver disease diagnostics

Pressemeddelelse30.5.2025, 06.00

ContextVision AB: ContextVision and AMRA Medical join forces to advance multimodal imaging in liver disease diagnostics

Selskabsmeddelelse13.5.2025, 13.45

ContextVision AB: BULLETIN FROM THE ANNUAL GENERAL MEETING OF CONTEXTVISION AB (PUBL)

Selskabsmeddelelse7.5.2025, 06.00

CONTX: ContextVision publishes Webcast for the Q1 report 2025

Selskabsmeddelelse7.5.2025, 06.00

ContextVision AB: Q1 interim report 2025 - Executing on our strategy for Image Quality and Data Quality

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.